Longevity Health Holdings, Inc. (XAGE) - Total Liabilities
Based on the latest financial reports, Longevity Health Holdings, Inc. (XAGE) has total liabilities worth $8.54 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See how liquid is Longevity Health Holdings, Inc.'s working capital to evaluate short-term liquidity relative to the company's equity base.
Longevity Health Holdings, Inc. - Total Liabilities Trend (2021–2025)
This chart illustrates how Longevity Health Holdings, Inc.'s total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Longevity Health Holdings, Inc. total assets.
Longevity Health Holdings, Inc. Competitors by Total Liabilities
The table below lists competitors of Longevity Health Holdings, Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
PETREL RESOURCES (PQ4.SG)
STU:PQ4
|
Germany | €1.22 Million |
|
Storage Drop Storage Technologies Ltd
TA:STRG
|
Israel | ILA3.25 Million |
|
Alkemy Capital Investments Plc
LSE:ALK
|
UK | GBX4.76 Million |
|
Devolver Digital Inc
LSE:DEVO
|
UK | GBX39.74 Million |
|
ROBUS GROUP AS EO -60
F:LH2
|
Germany | €165.85K |
|
EGR EXPL LTD
F:Z0R
|
Germany | €231.51K |
|
Fashion Bel Air S.A
PA:ALFBA
|
France | €5.19 Million |
|
CENTAURUS ENERGY INC.
F:72M0
|
Germany | €5.63 Million |
Liability Composition Analysis (2021–2025)
This chart breaks down Longevity Health Holdings, Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See net asset quality index of Longevity Health Holdings, Inc. to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.15 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.24 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 5.20 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Longevity Health Holdings, Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Longevity Health Holdings, Inc. (2021–2025)
The table below shows the annual total liabilities of Longevity Health Holdings, Inc. from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $8.23 Million | +33.09% |
| 2024-12-31 | $6.19 Million | -84.22% |
| 2023-12-31 | $39.20 Million | -0.86% |
| 2022-12-31 | $39.54 Million | +27.00% |
| 2021-12-31 | $31.13 Million | -- |
About Longevity Health Holdings, Inc.
Longevity Health Holdings, Inc., a bio-aesthetics company, focuses on developing, manufacturing, and marketing cosmetic skincare and haircare products. The company utilizes Carmell Secretome and Elevai Exosomes to support skin and hair health. Its Carmell Secretome consists of growth factors, proteins, and peptides extracted from allogeneic human platelets; and Elevai Exosomes constains growth fa… Read more